ΣΦ-4008

ΣΦ-4008 is an internal development code used by Sigmapharm Laboratories for a pharmaceutical product in their pipeline. According to company records, it is part of a series of products (ΣΦ-4001 through ΣΦ-4010) being prepared for regulatory submission, likely via the Abbreviated New Drug Application (ANDA) or New Drug Application (NDA) pathways. As Sigmapharm Laboratories focuses on the development of unique generic and specialty branded products, ΣΦ-4008 likely represents a formulation with specific barrier-to-entry properties, such as formulation challenges, patent-litigation risks, or bioavailability issues. However, the specific active ingredient, therapeutic indication, and molecular target have not been publicly disclosed.